Skip to content

The Effect of Neuro-orthosis on Gait Performer in Post Stroke Subjects

The Effect of Neuro-orthosis on Gait Performer in Chronic Post Stroke Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04266899
Enrollment
32
Registered
2020-02-12
Start date
2019-09-20
Completion date
2020-03-20
Last updated
2021-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Cerebrovascular Stroke, Cerebral Stroke, Cerebrovascular Accident, Neurorehabilitation, Gait Rehabilitation

Brief summary

The aim of this study is to verify the effectiveness of foot drop stimulation (FDS) on gait rehabilitation of post-stroke subjects with mild, moderate and severe compromise.

Detailed description

The stroke subjects are going to perform the walking training with Foot drop stimulator on the treadmill. All the evaluations will be performed with a foot drop stimulator turned off and on. One month later, that finished the intensive treatment; the participants were also evaluated only without the stimulation of FDS.

Interventions

DEVICEFoot Drop Stimulator - Neuro Orthosis

The WalkAide system is a self-contained functional electrical stimulation device with a built-in tilt sensor and attaches with a cuff to the leg below the knee. The device stimulates the peroneal nerve provides active dorsiflexion of muscle during the swing phase of gait.

DEVICETreadmill

Gait training on a treadmill

Sponsors

Federal University of Health Science of Porto Alegre
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects with ischemic or hemorrhagic stroke diagnosis. * Mild, moderate or severe hemiparesis (chronic stroke - at least 6 months) * Minimal cognitive ability to understand commands * Able to walk 10 meters unassisted or with minimal assistance

Exclusion criteria

* Secondary musculoskeletal disorder involving the lower limb * Contraindication for electrical stimulation

Design outcomes

Primary

MeasureTime frameDescription
Assessment of gait speedChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means of the 3-D motion analysis system (capture system BTS SMART DX 400)

Secondary

MeasureTime frameDescription
Changes in center of pressure displacementChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Assessed by force platform (BTS P-6000)
Postural ControlChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by Center of Pressure (COP) displacement assessed on force platform (BTS P-6000)
Functional MobilityChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means of the Timed Up & Go Test (TUG)
Muscular tone assessed by the Modified Ashworth ScaleChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Assessed by the Modified Ashworth Scale. This scale consists of 5 ordinal values ranging from 0 (no tonus increase) to 4 (stiffness).
Assessment of Sensorimotor Recovery After Stroke by Fugl-Meyer scaleChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Fugl-Meyer scale of lower limb impairment. The evaluation includes measurement of voluntary movement, velocity, coordination and reflex activity, through an ordinal scale applied to each item: 0- cannot be performed, 1- partially performed, and 2-performed completely. Participants were also classified according their LL motor impairment in severe (0 to19), moderate (20 to 28) or mild (\> 29 points).
Assessment of angular kinematics of hip, knee and ankleChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means of the 3-D motion analysis system (capture system BTS SMART DX 400)
Assessment of duration of stance and swing phase of gaitChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means inertial sensor (G-Sensor®, BTS Bioengineering, Italy), during 10 meters walking test.
Assessment of Stride length and Step length of gaitChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means inertial sensor (G-Sensor®, BTS Bioengineering, Italy), during 10 meters walking test.
Assessment of cadence by means number of steps by the minute.Change from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means inertial sensor (G-Sensor®, BTS Bioengineering, Italy), during 10 meters walking test.
Assessment of Harmonic Ration of GaitChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means single miniaturized inertial sensor (G-Sensor®, BTS Bioengineering, Italy). The device collects the values of linear accelerations along three orthogonal axes (antero-posterior (AP) corresponding to the walking direction, medio-lateral (ML), and supero-inferior (V)). The Harmonic Ration is the ratio between the sum of the amplitudes of even harmonics and the sum of the amplitudes of odd harmonics calculated via the discrete Fourier transform along the antero-posterior (AP) and cranio-caudal (CC) directions; the opposite ratio is calculated along the latero-lateral axis (LL).
Assessment of Gait speed in external environmentChange from Pre to Post treatment (2 weeks) and Post 3 (1 month follow-up)Evaluated by means inertial sensor (G-Sensor®, BTS Bioengineering, Italy) during 10 meters walking test.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026